PT - JOURNAL ARTICLE AU - Kolin, David A. AU - Kulm, Scott AU - Elemento, Olivier TI - Clinical and Genetic Characteristics of Covid-19 Patients from UK Biobank AID - 10.1101/2020.05.05.20075507 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.05.20075507 4099 - http://medrxiv.org/content/early/2020/05/05/2020.05.05.20075507.short 4100 - http://medrxiv.org/content/early/2020/05/05/2020.05.05.20075507.full AB - Objective To explore both clinical and genetic risk factors for Covid-19 in a cohort from the United Kingdom.Design Prospective cohort study.Participants 669 positive Covid-19 patients within a cohort of 502,536 UK Biobank participants, recruited between 2006 and 2010.Main Outcome Measures The main outcome measure was Covid-19 positive status, determined by the presence of any positive test for a single individual. We also assessed risk factors for inpatient and outpatient status for Covid-19 positive individuals.Results We found that black participants were at over three times increased risk of testing positive for Covid-19, relative to white participants, even after adjusting for confounders (adjusted relative risk [ARR] 3.14, 95% confidence interval [CI] 2.28 to 4.31). Asian participants were also at higher risk of Covid-19 (ARR 2.03, 95% CI 1.40 to 2.95). Next, we analyzed the association of comorbidities with Covid-19. We found that participants were at increased risk of Covid-19 if they had chronic obstructive pulmonary disease (ARR 1.54, 95% CI 1.02 to 2.31) or ischemic heart disease (ARR 1.56, 95% CI 1.18 to 2.07). However, there was no evidence that either angiotensin converting enzyme inhibitors (ARR 1.32, 95% CI 0.95 to 1.84) or angiotensin II receptor blockers (ARR 1.37, 95% CI 0.94 to 1.98) increased the risk of Covid-19. We confirmed that blood type A was associated with Covid-19 relative to blood type O individuals, and we also found that the HLA variant DQA1_509 was enriched in Covid-19 positive cases, even after Bonferroni correction (P = 1.0 x 10−5).Conclusions In this study, we found that black and Asian participants were at increased risk of Covid-19, even after adjusting for confounders. We also identified a novel genetic association with the HLA variant DQA1_509. Further investigations of genetic associations with Covid-19 may lead to important discoveries of genetic drivers of severe disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIH grants U24 CA210989, R01 CA194547, P50CA211024, UL1TR002384 and Emerson Collective Cancer Research Fund. There were no additional funding sources for this study, and the authors have no conflicts of interest to disclose.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUK Biobank is a cohort of over 500,000 patients that is accessible to all researchers via an application process.